Once-weekly Petrelintide Versus Placebo for Obesity or Overweight with Co-morbidities

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The main purpose of this study is to compare dose levels of petrelintide versus placebo with regards to effect on body weight, safety, and tolerability.
Epistemonikos ID: 79ad61e7eac400ed6b450d9953142853028bbe61
First added on: Nov 01, 2024